Grown Rogue International (GRUSF) Revenue Growth (1y) (2010 - 2026)
Grown Rogue International (GRUSF) Revenue Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.51 Bn | 87.64 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.21 Bn | 1.97 Bn | 2.34% |
| 3 | Zoetis | 32.59 Bn | 30.65 Bn | 1.62 Bn | 2.91% |
| 4 | Takeda Pharmaceutical | 27.51 Bn | 23.45 Bn | 4.39 Bn | -11.85% |
| 5 | United Therapeutics | 23.06 Bn | 20.91 Bn | 648.10 Mn | -1.62% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.25 Bn | 18.44 Bn | 1.16 Bn | 7.85% |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.48 Bn | 800.70 Mn | 42.25% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 14.92% |
| 10 | Grown Rogue International | 99.97 Mn | 86.26 Mn | 3.96 Mn | 28.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.05% |
| Dec 31, 2025 | -61,976,161.19% |
| Sep 30, 2025 | 104,632,296.30% |
| Jun 30, 2025 | 98,520,128.40% |
| Mar 31, 2025 | 7.45% |
| Dec 31, 2024 | 631.77% |
| Jan 31, 2023 | 21.37% |
| Jan 31, 2022 | 255.10% |
| Oct 31, 2021 | 255.83% |
| Jul 31, 2021 | 235.07% |
| Apr 30, 2021 | 31.20% |
| Jan 31, 2021 | -4.98% |
| Oct 31, 2020 | 144.82% |
| Jul 31, 2020 | 16.81% |
| Apr 30, 2020 | -37.80% |
| Jan 31, 2020 | 32.60% |
| Oct 31, 2019 | -45.38% |
| Jul 31, 2019 | 13.83% |
| Apr 30, 2019 | 547.75% |
| Jan 31, 2019 | 388.01% |